In June we will be conducting two in-depth courses on how to program in AmiBroker . These programming courses will be led by Matt Radtke, Director of Research at Connors Research. Matt is an expert AmiBroker programmer, and has a wealth of experience creating AmiBroker scans and backtests to simulate a wide variety of trading… [Read More]
Unemployment Reports, Volatility and Potential PowerRatings Buys
Every month, the unemployment report has the potential to move markets. Some studies have found that the trading range of broad market indexes is three times greater than average on the day after the report. Unemployment has taken on greater significance since the Federal Reserve pegged low interest rates and easy money to the unemployment… [Read More]
Questions from Congress About Drug Prices Lead to PowerRatings Signals
Gilead Sciences (NASDAQ: GILD) recently began offering a new hepatitis drug. Experts note that GILD’s drug helps about 90% of patients who take the drug and has few side effects. Older drugs only helped about half of the patients and had a number of side effects. While GILD’s drug offers medical benefits, the price tag… [Read More]
Thursday Selloff Creates 182 Buying Opportunities
While we have seen a great deal of volatility in prices over the past few weeks, we have not seen a large number of ETFs become overbought or oversold on any given day. Yesterday’s selling led to a number of buy set ups on PowerRatings. Heading into Friday’s trading, 113 non-leveraged ETFs, an additional 32… [Read More]
AKRX Oversold on Three Indicators After Earnings Disappointment
Specialty drug maker Akorn (NASDAQ: AKRX) dropped more than 18% on Tuesday after reporting earnings that beat estimates for the quarter but disappointed investors when management provided guidance for 2014 that was lower than analysts expected. The stock is now oversold on a number of indicators including ConnorsRSI and PowerRatings. Heading into today’s trading AKRX… [Read More]
PowerRatings Highlight Two Sectors for Potential Rebound
Yesterday’s market selloff did not push many stocks or ETFs into oversold territory according to PowerRatings which identifies high probability trading opportunities. Only two sector ETFs are oversold with PowerRatings of 8, Utilities Select Sector SPDR (NYSE: XLU) and SPDR S&P Biotech ETF (NYSE: XBI). Among individual stocks, there are also relatively few buy setups…. [Read More]
Questions About Questcor Lead to Another Oversold Market Leader
Some of last year’s biggest winners have been selling off over the past several weeks and providing potential buying opportunities. Questcor Pharmaceuticals (NASDAQ: QCOR) is the latest stock to pull back after recording large gains in the bull market. QCOR gained more than 1,800% since 2008 and more than doubled last year. The company derives… [Read More]
Market Leader Micron Technology Oversold
Micron Technology (NYSE: MU) has been among the leaders in the bull market that began in 2009 with a gain of more than 1,400% since bottoming in the bear market. In 2013, MU was once again among the biggest gainers in the S&P 500 with a gain of more than 250%. In the first weeks… [Read More]
LivePerson Disappoints Investors and Becomes a Potential Buy
LivePerson (NASDAQ: LPSN) provides companies with the ability to connect with their customers in real-time with chat, voice and video services through websites, social media and mobile devices. The company recorded more than $173 million in sales over the past twelve months. In the most recent quarter, LPSN announced results yesterday that beat analysts’ earnings… [Read More]
Inverse Financial ETF FAZ Oversold as Traders Wait for News
Financial stocks are highly correlated to changes in interest rates and Federal Reserve Chair Janet Yellen’s Congressional testimony will bring attention to interest rates today. Yellen may or may not say anything of substance but traders and analysts will attempt to find meaning in her words. Market volatility is likely to increase based on speculation… [Read More]
- 1
- 2
- 3
- …
- 31
- Next Page »